Difluoroacetic Acid Mobile Phase Additive for LC-MS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for protein liquid chromatography-mass spectrometry (LC-MS) face challenges with trifluoroacetic acid (TFA) suppressing electrospray ionization signals and complicating mass spectra due to gas-phase ion pair formation, while alternative additives like formic acid fail to achieve optimal resolving power.
Innovation Solution
The use of low concentrations of difluoroacetic acid (DFA) as a mobile phase additive, with or without phenyl-based stationary phases, to enhance chromatographic and mass spectrometric performance, achieving high sensitivity and resolution while minimizing metal impurities to improve interpretability of mass spectra.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If trifluoroacetic acid (TFA) is used as mobile phase additive, then chromatographic resolving power is improved, but electrospray ionization signal is suppressed and mass spectra are complicated
Solution Approach 1:
The patent changes the chemical parameters of the mobile phase additive by using difluoroacetic acid (DFCA) instead of trifluoroacetic acid (TFA). This parameter change maintains the ion-pairing capability needed for chromatographic resolution while reducing the harmful effects on electrospray ionization and mass spectral quality, as DFCA has different physicochemical properties that are more compatible with MS detection
Solution Approach 2:
The patent introduces difluoroacetic acid as an intermediary substance that mediates between the conflicting requirements of chromatographic separation and mass spectrometry detection. DFCA serves as a compromise mobile phase additive that provides sufficient ion-pairing for resolution while being less detrimental to ESI-MS signals compared to TFA
2Object-generated harmful factors
If formic acid is used as mobile phase additive, then electrospray ionization signal is improved, but chromatographic resolving power deteriorates
Solution Approach 1:
The patent changes the strength and chemical properties of the mobile phase additive by selecting difluoroacetic acid, which has intermediate properties between formic acid and TFA. This parameter change allows achieving both good ESI signals and adequate chromatographic resolution, overcoming the limitations of using formic acid alone
3Manufacturing precision
If high concentration of mobile phase additive is used, then chromatographic retention is improved, but mass spectrometric sensitivity deteriorates
Solution Approach 1:
The patent changes the concentration parameter of the mobile phase additive to low levels (0.01-0.1% v/v), which is sufficient to achieve adequate chromatographic retention when using DFCA, while minimizing the negative impact on mass spectrometric sensitivity. This optimized concentration parameter balances both chromatographic and spectrometric performance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
DFA-based methods provide higher MS sensitivity and chromatographic resolution, enabling subunit-level characterization of protein therapeutics with reduced on-column sample degradation and improved detection of trace impurities, setting a new standard for high-resolution, high-sensitivity LC-MS of proteins.
Implementation Method 1
ion pairing with a hydrophobic, acidic mobile phase additive
Implementation Method 2
Protein reversed phase liquid chromatography
Implementation Method 3
Electrospray ionization (ESI)
Implementation Method 4
separating the ions according to their mass-to-charge ratio
Data Source
Figure 1A~1D
Figure 1E~1H
Figure 1I~1K
AI summary
The present disclosure relates to the determination of analytes in a sample using chromatography. The present disclosure provides methods of separating an analyte from a sample. A mobile phase is flowed through a chromatography column. The mobile phase includes about 0.005% (v/v) to about 0.20% (v/v) difluoroacetic acid and less than about 100 ppb of any individual metal impurity. A sample including the analyte is injected into the mobile phase. The analyte is separated from the sample.